313 related articles for article (PubMed ID: 19954311)
1. Bosentan for chronic thromboembolic pulmonary hypertension.
Confalonieri M; Kodric M; Longo C; Vassallo FG
Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1503-12. PubMed ID: 19954311
[TBL] [Abstract][Full Text] [Related]
2. Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial.
Jaïs X; D'Armini AM; Jansa P; Torbicki A; Delcroix M; Ghofrani HA; Hoeper MM; Lang IM; Mayer E; Pepke-Zaba J; Perchenet L; Morganti A; Simonneau G; Rubin LJ;
J Am Coll Cardiol; 2008 Dec; 52(25):2127-34. PubMed ID: 19095129
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of bosentan in inoperable chronic thromboembolic pulmonary hypertension: a 1-year follow-up study.
Hughes RJ; Jais X; Bonderman D; Suntharalingam J; Humbert M; Lang I; Simonneau G; Pepke-Zaba J
Eur Respir J; 2006 Jul; 28(1):138-43. PubMed ID: 16611652
[TBL] [Abstract][Full Text] [Related]
4. Chronic thromboembolic pulmonary hypertension: role of medical therapy.
Pepke-Zaba J; Jansa P; Kim NH; Naeije R; Simonneau G
Eur Respir J; 2013 Apr; 41(4):985-90. PubMed ID: 23397304
[TBL] [Abstract][Full Text] [Related]
5. Bosentan for the treatment of adult pulmonary hypertension.
Dwyer N; Kilpatrick D
Future Cardiol; 2011 Jan; 7(1):19-37. PubMed ID: 21174507
[TBL] [Abstract][Full Text] [Related]
6. Long-term bosentan in chronic thromboembolic pulmonary hypertension.
Seyfarth HJ; Hammerschmidt S; Pankau H; Winkler J; Wirtz H
Respiration; 2007; 74(3):287-92. PubMed ID: 16699254
[TBL] [Abstract][Full Text] [Related]
7. Bosentan therapy for inoperable chronic thromboembolic pulmonary hypertension.
Bonderman D; Nowotny R; Skoro-Sajer N; Jakowitsch J; Adlbrecht C; Klepetko W; Lang IM
Chest; 2005 Oct; 128(4):2599-603. PubMed ID: 16236930
[TBL] [Abstract][Full Text] [Related]
8. Bosentan therapy for pulmonary arterial hypertension.
Rubin LJ; Badesch DB; Barst RJ; Galie N; Black CM; Keogh A; Pulido T; Frost A; Roux S; Leconte I; Landzberg M; Simonneau G
N Engl J Med; 2002 Mar; 346(12):896-903. PubMed ID: 11907289
[TBL] [Abstract][Full Text] [Related]
9. Cardiopulmonary exercise testing to evaluate the exercise capacity of patients with inoperable chronic thromboembolic pulmonary hypertension: an endothelin receptor antagonist improves the peak PETCO2.
Hirashiki A; Adachi S; Nakano Y; Kono Y; Shimazu S; Shimizu S; Morimoto R; Okumura T; Takeshita K; Yamada S; Murohara T; Kondo T
Life Sci; 2014 Nov; 118(2):397-403. PubMed ID: 24641953
[TBL] [Abstract][Full Text] [Related]
10. Bosentan.
Chin K; Channick R
Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):175-82. PubMed ID: 15151466
[TBL] [Abstract][Full Text] [Related]
11. Bosentan as a bridge to pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension.
Reesink HJ; Surie S; Kloek JJ; Tan HL; Tepaske R; Fedullo PF; Bresser P
J Thorac Cardiovasc Surg; 2010 Jan; 139(1):85-91. PubMed ID: 19660388
[TBL] [Abstract][Full Text] [Related]
12. Bosentan therapy for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: A systemic review and meta-analysis.
Chen X; Zhai Z; Huang K; Xie W; Wan J; Wang C
Clin Respir J; 2018 Jun; 12(6):2065-2074. PubMed ID: 29393580
[TBL] [Abstract][Full Text] [Related]
13. Medical therapies for chronic thromboembolic pulmonary hypertension: an evolving treatment paradigm.
Bresser P; Pepke-Zaba J; Jaïs X; Humbert M; Hoeper MM
Proc Am Thorac Soc; 2006 Sep; 3(7):594-600. PubMed ID: 16963540
[TBL] [Abstract][Full Text] [Related]
14. Bosentan therapy for inoperable chronic thromboembolic pulmonary hypertension.
Hoeper MM; Kramm T; Wilkens H; Schulze C; Schäfers HJ; Welte T; Mayer E
Chest; 2005 Oct; 128(4):2363-7. PubMed ID: 16236895
[TBL] [Abstract][Full Text] [Related]
15. Survival in patients with pulmonary arterial hypertension treated with first-line bosentan.
McLaughlin VV
Eur J Clin Invest; 2006 Sep; 36 Suppl 3():10-5. PubMed ID: 16919005
[TBL] [Abstract][Full Text] [Related]
16. Is distal chronic thromboembolic pulmonary hypertension treatable with PAH targeted drugs?
Cannon JE; Pepke-Zaba J
Semin Respir Crit Care Med; 2013 Oct; 34(5):620-6. PubMed ID: 24037629
[TBL] [Abstract][Full Text] [Related]
17. Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase II study.
Ghofrani HA; Hoeper MM; Halank M; Meyer FJ; Staehler G; Behr J; Ewert R; Weimann G; Grimminger F
Eur Respir J; 2010 Oct; 36(4):792-9. PubMed ID: 20530034
[TBL] [Abstract][Full Text] [Related]
18. Bosentan: a review of its use in the management of mildly symptomatic pulmonary arterial hypertension.
Dhillon S; Keating GM
Am J Cardiovasc Drugs; 2009; 9(5):331-50. PubMed ID: 19791841
[TBL] [Abstract][Full Text] [Related]
19. Bosentan for patients with chronic thromboembolic pulmonary hypertension.
Vassallo FG; Kodric M; Scarduelli C; Harari S; Potena A; Scarda A; Piattella M; Cassandro R; Confalonieri M
Eur J Intern Med; 2009 Jan; 20(1):24-9. PubMed ID: 19237088
[TBL] [Abstract][Full Text] [Related]
20. Bosentan in Eisenmenger syndrome and chronic thromboembolic pulmonary hypertension.
Kourouklis S; Christopoulos A; Liagkas K; Paradellis G; Kyriakides ZS
Eur J Clin Invest; 2006 Sep; 36 Suppl 3():39-43. PubMed ID: 16919009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
